Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

02 Nov 2022 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a press release today titled ‘Glenmark Pharmaceuticals receives ANDA approval for Sodium Phenylbutyrate Tablets USP, 500 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..